Tilman Schmidt Sara Afonso Luce Perie Karin Heidenreich Sonia Wulf Christian F Krebs Peter F Zipfel Thorsten Wiech
10.3389/fimmu.2022.826513
Front Immunol
2022 May 27;13:826513.
c3 glomerulopathy fhl1 complement eculizumab factor h membranoproliferative glomerulonephritis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35693785/
Complement C3 Glomerulonephritis, Membranoproliferative / diagnosis Glomerulonephritis, Membranoproliferative / therapy
Complement C3 Glomerulonephritis, Membranoproliferative / diagnosis Glomerulonephritis, Membranoproliferative / therapy Case Reports Research Support, Non-U.S. Gov't Adult Complement Activation Complement Pathway, Alternative / genetics Female Humans Immunoglobulins / therapeutic use Complement C3 Immunoglobulins
PMC9186056
35693785
An Interdisciplinary Diagnostic Approach to Guide Therapy in C3 Glomerulopathy
2022